INFORMATIONAL PURPOSES ONLY. Not medical, legal, or travel advice. Verify with official sources before acting. See corrections log.
Right to try laws and requirements in Alaska. Citations, verification dates, and source links for every data point.
| Dimension | Value | Citation | Source | Verified | Confidence |
|---|---|---|---|---|---|
| Have Enacted State Right to Try Laws | have state RTT laws | AS 08.64.367(c)-(d); AS 09.65.325 (HB 43, ch. 53 SLA 2018)“A physician may not be subject to disciplinary action by the board for prescribing, dispensing, or administering an investigational drug, biological product, or device, or providing related treatment, to a patient for the purpose of sustaining the patient's life” | Link | 2026-10-09 | high |
| Enacted Right to Try Laws Before Federal Law | 2018 | HB 43, ch. 53 SLA 2018“(H) SIGNED INTO LAW 7/13 CHAPTER 53 SLA 18” | Link | 2026-10-09 | high |
| Require Individualized Manufacturer Approval for RTT | do not require individualized approval | Goldwater Institute list of states enacting Right to Try for Individualized Treatments (as of May 30, 2025)“The Lone Star State is now the fifteenth state since 2022 to champion this crucial expansion, joining Colorado, Iowa, Louisiana, Indiana, Georgia, Maryland, Mississippi, Arizona, Nevada, North Carolina, Arkansas, Tennessee, Kansas and South Dakota” | Link | 2026-10-09 | medium |
| Provide Manufacturer Liability Protection Under RTT | provide liability shield | AS 09.65.325(a)(2)“A person is not liable in an action for damages for the injury or death of a patient with a terminal illness resulting from the patient's use of an investigational drug, biological product, or device”Note: Immunity clause (enacted by HB 43 sec. 2, 2018) expressly covering a 'manufacturer, importer, or distributor', conditioned on acting in good faith and with reasonable care, presenting FDA-approved options to the physician and giving the patient written notice of the immunity. Stored FALSE is wrong. | Link | 2026-10-09 | high |
| Require Insurer Coverage of Investigational Treatments | do not require coverage | HB 43, ch. 53 SLA 2018 (AS 08.64.367, 09.65.325, 17.20.110, 47.32.030)“Relating to prescribing, dispensing, and administering an investigational drug, biological product, or device by physicians for patients who are terminally ill for the purpose of sustaining the patient's life; providing immunity related to manufacturing, distributing” | Link | 2026-10-09 | high |
View full Alaska profile (all layers) · Report an error on this page